Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

A strange thing happened weeks before the Food and Drug Administration approved the first treatment made with CRISPR gene editing, an all-but cure for certain patients with sickle cell disease.

But amid all the fervor and history-making lies a few teething issues. Namely, even with the improved specificity CRISPR-Cas9 has brought to gene-editing, accidental, off-target effects still happen.

Autophagy is the process by which cells digest and renew their internal structures, recycling damaged or malfunctioning ...

We bring on our colleague Jason Mast to discuss the dramatic downturn in the once-swaggering field of CRISPR gene editing. We also talk about the advancement of RFK Jr.’s nomination to be HHS ...

Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...

The Rice lab of bioengineer Gang Bao and collaborators at Baylor College of Medicine have developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the ...

Both CRISPR systems reduced serum PCSK9 protein to undetectable levels. NanoCas also demonstrated 10% to 40% editing of the dystrophin gene across the quadricep, calf, and heart muscle in a ...